Publications by authors named "Christoph Zielinski"

100Publications

Direct oral anticoagulants compared to low-molecular-weight heparin for the treatment of cancer-associated thrombosis: Updated systematic review and meta-analysis of randomized controlled trials.

Res Pract Thromb Haemost 2020 May 21;4(4):550-561. Epub 2020 May 21.

Clinical Division of Haematology and Haemostaseology Department of Medicine I Comprehensive Cancer Center Vienna Medical University of Vienna Vienna Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/rth2.12359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292654PMC
May 2020

A Proposal to Redefine Pathologic Complete Remission as Endpoint following Neoadjuvant Chemotherapy in Early Breast Cancer.

Breast Care (Basel) 2020 Feb 27;15(1):67-71. Epub 2019 May 27.

Comprehensive Cancer Center, General Hospital, Medical University Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000500620DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098275PMC
February 2020

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an pro and con discussion.

ESMO Open 2019 13;4(6):e000565. Epub 2019 Nov 13.

Vienna Cancer Center, Medical University of Vienna and Vienna Hospital Association, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2019-000565DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863664PMC
June 2020

GDF-15 in solid vs non-solid treatment-naïve malignancies.

Eur J Clin Invest 2019 Nov 26;49(11):e13168. Epub 2019 Sep 26.

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/eci.13168DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899906PMC
November 2019

The role of ADAMTS-13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study.

Res Pract Thromb Haemost 2019 Jul 6;3(3):503-514. Epub 2019 May 6.

Clinical Division of Hematology and Hemostaseology Department of Medicine I Medical University of Vienna Vienna Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/rth2.12197DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611368PMC
July 2019

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an "ESMO Open - Cancer Horizons" Series.

ESMO Open 2019 12;4(Suppl 3):e000501. Epub 2019 Jun 12.

Vienna Cancer Center, City of Vienna - Medical University Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2019-000501DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579570PMC
June 2019

How I treat cancer special issue.

ESMO Open 2019 1;4(Suppl 2):e000514. Epub 2019 May 1.

Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2019-000514DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555613PMC
May 2019

SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment.

Transl Oncol 2019 Jan 20;12(1):15-23. Epub 2018 Sep 20.

Department of Internal Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2018.08.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149193PMC
January 2019

RE: Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration.

J Natl Cancer Inst 2018 10;110(10):1142-1143

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy029DOI Listing
October 2018

welcomes the association with the Japanese Society of Medical Oncology (JSMO).

ESMO Open 2017 4;2(3):e000240. Epub 2017 Aug 4.

Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2017-000240DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703397PMC
August 2017

Saudi lung cancer management guidelines 2017: Improving lung cancer care in Saudi region.

Ann Thorac Med 2017 Oct-Dec;12(4):219-220

Department of Medicine I, Clinical Division of Oncology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/atm.ATM_225_17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656940PMC
November 2017

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.

J Clin Oncol 2018 01 26;36(1):7-13. Epub 2017 Oct 26.

Vivek Subbiah and Maria E. Cabanillas, The University of Texas MD Anderson Cancer Center, Houston, TX; Robert J. Kreitman, National Institutes of Health, Bethesda, MD; Zev A. Wainberg, University of California Los Angeles, Los Angeles, CA; Jae Yong Cho, Yonsei University College of Medicine Gangnam Severance Hospital; Bhumsuk Keam, Seoul National University Hospital, Seoul, Republic of Korea; Jan H.M. Schellens, Netherlands Cancer Institute, Amsterdam; Jan H.M. Schellens, Utrecht Institute for Pharmaceutical Sciences, Utrecht, the Netherlands; Jean Charles Soria, Institut Gustave Roussy, University of Paris-Sud, and University of Paris-Saclay, Villejuif, France; Patrick Y. Wen, Dana-Farber Cancer Institute, Boston, MA; Christoph Zielinski, Comprehensive Cancer Center, Medical University Vienna; Vienna, Austria; and Gladys Urbanowitz, Bijoyesh Mookerjee, Dazhe Wang, and Fatima Rangwala, Novartis Oncology, East Hanover, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.6785DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791845PMC
January 2018

One year of : -where are we going from here?

ESMO Open 2016 23;1(6):e000153. Epub 2017 Jan 23.

Department of Medicine I and Comprehensive Cancer Center, Medical University of Vienna-General Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2016-000153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548973PMC
January 2017

Educational video: the role of PD-L1 in the local tumour microenvironment.

ESMO Open 2016 1;1(6):e000137. Epub 2017 Feb 1.

Central European Cooperative Oncology Group (CECOG), Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2016-000137DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548971PMC
February 2017

CECOG educational illustrations: the blood-brain barrier and its relevance for targeted cancer therapies and immuno-oncology.

ESMO Open 2017 8;2(2):e000194. Epub 2017 Jun 8.

Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2017-000194DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519816PMC
June 2017

Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide.

BMC Cancer 2017 02 9;17(1):118. Epub 2017 Feb 9.

Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3098-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301331PMC
February 2017

Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases-development and validation of the LabBM score.

Neuro Oncol 2017 Sep;19(9):1255-1262

Department of Medicine I, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland; Biostatistics Division, German Cancer Research Center, Heidelberg, Germany; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria; Department of Radiotherapy, Medical University of Vienna, Vienna, Austria; Department of Pathology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now290DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570252PMC
September 2017

CSCO joins ESMO Open-Cancer Horizons.

ESMO Open 2016 18;1(5):e000120. Epub 2016 Nov 18.

Guangdong Lung Cancer Institute, Guangzhou, Guangdong, People's Republic of China; Chinese Society of Clinical Oncology (CSCO), Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2016-000120DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133379PMC
November 2016

AIOM chooses as its official journal: a warm welcome from .

ESMO Open 2016 1;1(4):e000080. Epub 2016 Jul 1.

Reggio Emilia , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2016-000080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070276PMC
July 2016

Cancer immune cycle: a video introduction to the interaction between cancer and the immune system.

ESMO Open 2016 12;1(3):e000056. Epub 2016 Apr 12.

Central European Cooperative Oncology Group (CECOG) , Vienna , Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2016-000056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070358PMC
April 2016

Recent developments and translational aspects in targeted therapy for metastatic breast cancer.

ESMO Open 2016 4;1(3):e000036. Epub 2016 May 4.

Department for Internal Medicine I-Oncology , Comprehensive Cancer Center and Medical University Vienna , Vienna , Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2016-000036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070263PMC
May 2016

Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers.

ESMO Open 2016 16;1(2):e000024. Epub 2016 Mar 16.

Department of Medicine I, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2015-000024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070252PMC
March 2016

and the future of oncology.

ESMO Open 2016 18;1(1):e000008. Epub 2016 Jan 18.

Department of Medicine I , Comprehensive Cancer Center, Medical University Vienna , Vienna , Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2015-000008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070212PMC
January 2016

Sustained Response to Vemurafenib in a BRAF-Mutated Anaplastic Thyroid Carcinoma Patient.

Thyroid 2016 10 27;26(10):1515-1516. Epub 2016 Sep 27.

1 Department of Medicine I, Comprehensive Cancer Center Vienna; Medical University of Vienna , Vienna, Austria .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2015.0575DOI Listing
October 2016

Risk factors for Clostridium difficile infection in hemato-oncological patients: A case control study in 144 patients.

Sci Rep 2016 08 11;6:31498. Epub 2016 Aug 11.

Department of Internal Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep31498DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980611PMC
August 2016

Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer.

J Clin Oncol 2016 11;34(31):3740-3748

Martin Reck, LungenClinic Grosshansdorf, Airway Research Center North, Grosshansdorf; Michael Thomas, Translational Lung Research Center Heidelberg, Thoraxklinik im Universitätsklinikum Heidelberg, Heidelberg, Germany; Alexander Luft, Leningrad Regional Clinical Hospital, Leningrad, Russia; Aleksandra Szczesna, Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy w Otwocku, Otwocku, Poland; Libor Havel, Hospital Na Bulovce, Prague, Czech Republic; Sang-We Kim, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea; Wallace Akerley, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Maria Catherine Pietanza, Memorial Sloan Kettering Cancer Center, New York, NY; Kathryn Gold, University of Texas MD Anderson Cancer Center, Houston, TX; Leora Horn, Vanderbilt-Ingram Cancer Center; David Spigel, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Anne Pieters, Teresa Kong Sanchez, and Justin Fairchild, Bristol-Myers Squibb, Princeton, NJ; Yi-long Wu, Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong, People's Republic of China; Christoph Zielinski, Medical University of Vienna, Vienna, Austria; Enriqueta Felip, Vall d'Hebron University Hospital, Barcelona, Spain; Joachim Aerts, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Kazuhiko Nakagawa, Kinki University Hospital, Osaka, Japan; and Paul Lorigan, the Christie NHS Foundation Trust, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.67.6601
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.67.6601DOI Listing
November 2016

Phase II trial of capecitabine plus nab-paclitaxel in patients with metastatic pancreatic adenocarcinoma.

J Gastrointest Oncol 2016 Apr;7(2):234-8

1 Department of Internal Medicine I, Medical University Vienna, Vienna, Austria ; 2 Department of Surgery, Landesklinikum Wiener Neustadt, Wiener Neustadt, Austria ; 3 Department of Surgery, Medical University Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2078-6891.2015.107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783742PMC
April 2016

Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases.

Oncoimmunology 2016;5(1):e1057388. Epub 2015 Jun 9.

Department for Medicine I/Clinical Division of Oncology; Medical University of Vienna; Vienna, Austria; Comprehensive Cancer Center - CNS Tumors Unit; Medical University of Vienna; Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1057388DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760339PMC
June 2015

Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients.

Oncologist 2016 Feb 13;21(2):252-7. Epub 2016 Jan 13.

Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria Comprehensive Cancer Center, Vienna, Austria

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0284DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746083PMC
February 2016

Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A Multi-State Model.

Thromb Haemost 2016 Apr 7;115(4):817-26. Epub 2016 Jan 7.

Dr. Cihan Ay, Medical University of Vienna, Department of Medicine I, Clinical Division of Haematology and Haemostaseology, Währinger Gürtel 18-20, 1090 Vienna, Austria, Tel.: +43 1 40400 4410, Fax: +43 1 40400 4030, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH15-09-0758DOI Listing
April 2016

Predictive role of hand-foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer.

Br J Cancer 2016 Jan 10;114(2):163-70. Epub 2015 Dec 10.

Clinical Division of Oncology, Department of Medicine I and Comprehensive Cancer Center, Medical University Vienna - General Hospital, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2015.419DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815806PMC
January 2016

Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patients.

Thromb Res 2015 Nov 28;136(5):865-9. Epub 2015 Aug 28.

Department of Internal Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2015.08.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496222PMC
November 2015

In vivo Tube Assay: An Optimised Protocol of the Directed in vivo Angiogenesis Assay by Implementing Immunohistochemistry.

J Vasc Res 2015 31;52(2):116-26. Epub 2015 Jul 31.

Clinical Division of Oncology, Department of Medicine I and Comprehensive Cancer Center Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000434751DOI Listing
December 2015

Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants.

Thromb Res 2015 Sep 17;136(3):582-9. Epub 2015 Jul 17.

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2015.07.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311195PMC
September 2015

Effects of cilengitide in osteoclast maturation and behavior.

Exp Cell Res 2015 Sep 21;337(1):68-75. Epub 2015 Jul 21.

Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2015.07.018DOI Listing
September 2015

Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma.

Eur J Cancer 2015 Sep 8;51(13):1803-11. Epub 2015 Jul 8.

Department of Pathology, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, Central Nervous System Unit (CCC-CNS), Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.06.107DOI Listing
September 2015

Non-Small-Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy.

J Thorac Oncol 2015 Jul;10(7):974-84

*Ohio State University Medical Center, Columbus, Ohio; †University of California Davis Comprehensive Cancer Center, Sacramento, California; ‡H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida; §Comprehensive Cancer Center, Medical University of Vienna General Hospital, Vienna, Austria; and ‖Instituto de Biomedicina de Sevilla, Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000551DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618296PMC
July 2015

Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cells.

Am J Cancer Res 2015 15;5(2):560-74. Epub 2015 Jan 15.

Ludwig Boltzmann Cluster Oncology, Medical University of Vienna Waehringer Guertel 18-20, A-1090 Vienna, Austria ; Department of Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna Waehringer Guertel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396035PMC
May 2015

Association of platelet activation markers with cancer-associated venous thromboembolism.

Platelets 2016 13;27(1):80-5. Epub 2015 May 13.

a Clinical Division of Haematology and Haemostaseology, Department of Medicine I , Comprehensive Cancer Center Vienna, Medical University of Vienna , Vienna , Austria .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/09537104.2015.1041901DOI Listing
October 2016

A phase I study of MEDI4736, NNT-PD-L1 antibody in patients with advanced solid tumors.

Transl Lung Cancer Res 2014 Dec;3(6):406-7

1 Clinical Division of Oncology and Chairman, Department of Medicine I, 2 Comprehensive Cancer Center, Medical University Vienna, General Hospital, Vienna, Austria ; 3 Central European Cooperative Oncology Group, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2014.08.07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367668PMC
December 2014

Influenza vaccination perception and coverage among patients with malignant disease.

Vaccine 2015 Mar 24;33(14):1682-7. Epub 2015 Feb 24.

Clinical Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2015.02.029DOI Listing
March 2015

Novel agents have a significant impact on survival of patients with multiple myeloma.

Wien Klin Wochenschr 2015 Feb 22;127(3-4):92-7. Epub 2015 Jan 22.

Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-014-0605-6DOI Listing
February 2015

Public perception of cancer care in Poland and Austria.

Oncologist 2015 Jan 17;20(1):28-36. Epub 2014 Dec 17.

Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0226DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294605PMC
January 2015

Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol.

Support Care Cancer 2015 Jun 30;23(6):1741-8. Epub 2014 Nov 30.

Department of Medicine I, Clinical Division of Oncology, Comprehensive Cancer Center of the Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-014-2535-2DOI Listing
June 2015

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.

Neuro Oncol 2015 Aug 29;17(8):1064-75. Epub 2014 Oct 29.

Institute of Neurology, Medical University of Vienna, Vienna, Austria (A.S.B., G.R., A.W., J.A.H.); Department of Medicine I, Medical University of Vienna, Vienna, Austria (A.S.B., O.R., M.F., A.B., C.C.Z., C.M., M.P.); Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria (A.S.B., B.K., G.W., O.R., G.R., A.W., K.D., M.F., A.B., C.C.Z., C.M., J.A.H., M.P.); Department of Neurosurgery, Medical University of Vienna, Vienna, Austria (B.K., G.W.); Department of Radiotherapy, Medical University of Vienna, Vienna, Austria (K.D.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Laboratory of Brain Tumor Biology and Genetics, Service of Neurosurgery, Department of Clinical Neurosciences, University Hospital Lausanne (CHUV), Lausanne, Switzerland (S.K., M.E.H.); Neurology Clinic and National Center for Tumor Disease, University of Heidelberg, Heidelberg, Germany (W.W.); Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany (W.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou307DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490866PMC
August 2015